These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 34482637)
1. Transition from mild cognitive impairment to normal cognition: Determining the predictors of reversion with multi-state Markov models. Sanz-Blasco R; Ruiz-Sánchez de León JM; Ávila-Villanueva M; Valentí-Soler M; Gómez-Ramírez J; Fernández-Blázquez MA Alzheimers Dement; 2022 Jun; 18(6):1177-1185. PubMed ID: 34482637 [TBL] [Abstract][Full Text] [Related]
2. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia. Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799 [TBL] [Abstract][Full Text] [Related]
3. Cognitive Reserve and Mild Cognitive Impairment: Predictors and Rates of Reversion to Intact Cognition vs Progression to Dementia. Iraniparast M; Shi Y; Wu Y; Zeng L; Maxwell CJ; Kryscio RJ; St John PD; SantaCruz KS; Tyas SL Neurology; 2022 Mar; 98(11):e1114-e1123. PubMed ID: 35121669 [TBL] [Abstract][Full Text] [Related]
4. Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms. McGirr A; Nathan S; Ghahremani M; Gill S; Smith EE; Ismail Z Neurology; 2022 May; 98(21):e2132-e2139. PubMed ID: 35351783 [TBL] [Abstract][Full Text] [Related]
5. Estimating Bidirectional Transitions and Identifying Predictors of Mild Cognitive Impairment. Qin Y; Han H; Li Y; Cui J; Jia H; Ge X; Ma Y; Bai W; Zhang R; Chen D; Yi F; Yu H Neurology; 2023 Jan; 100(3):e297-e307. PubMed ID: 36220593 [TBL] [Abstract][Full Text] [Related]
6. Multi-state Markov model in outcome of mild cognitive impairments among community elderly residents in Mainland China. Yu HM; Yang SS; Gao JW; Zhou LY; Liang RF; Qu CY Int Psychogeriatr; 2013 May; 25(5):797-804. PubMed ID: 23286508 [TBL] [Abstract][Full Text] [Related]
7. Predictors of Reversion from Mild Cognitive Impairment to Normal Cognition. Pandya SY; Lacritz LH; Weiner MF; Deschner M; Woon FL Dement Geriatr Cogn Disord; 2017; 43(3-4):204-214. PubMed ID: 28301848 [TBL] [Abstract][Full Text] [Related]
8. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition. Tokuchi R; Hishikawa N; Kurata T; Sato K; Kono S; Yamashita T; Deguchi K; Abe K J Neurol Sci; 2014 Nov; 346(1-2):288-92. PubMed ID: 25248955 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic transitions in mild cognitive impairment by use of simple Markov models. Facal D; Guàrdia-Olmos J; Juncos-Rabadán O Int J Geriatr Psychiatry; 2015 Jul; 30(7):669-76. PubMed ID: 25315251 [TBL] [Abstract][Full Text] [Related]
10. Predicting the reversion from mild cognitive impairment to normal cognition based on magnetic resonance imaging, clinical, and neuropsychological examinations. Yu HH; Tan CC; Huang SJ; Zhang XH; Tan L; Xu W; J Affect Disord; 2024 May; 353():90-98. PubMed ID: 38452935 [TBL] [Abstract][Full Text] [Related]
11. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia. Morris JC Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163 [TBL] [Abstract][Full Text] [Related]
12. Reversion from mild cognitive impairment to normal or near-normal cognition: risk factors and prognosis. Koepsell TD; Monsell SE Neurology; 2012 Oct; 79(15):1591-8. PubMed ID: 23019264 [TBL] [Abstract][Full Text] [Related]
13. Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease. Donovan NJ; Amariglio RE; Zoller AS; Rudel RK; Gomez-Isla T; Blacker D; Hyman BT; Locascio JJ; Johnson KA; Sperling RA; Marshall GA; Rentz DM Am J Geriatr Psychiatry; 2014 Dec; 22(12):1642-51. PubMed ID: 24698445 [TBL] [Abstract][Full Text] [Related]
14. Internal Consistency Over Time of Subjective Cognitive Decline: Drawing Preclinical Alzheimer's Disease Trajectories. Ávila-Villanueva M; Maestú F; Fernández-Blázquez MA J Alzheimers Dis; 2018; 66(1):173-183. PubMed ID: 30248053 [TBL] [Abstract][Full Text] [Related]
15. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample. Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924 [TBL] [Abstract][Full Text] [Related]
16. The Transition of Mild Cognitive Impairment Over Time: An AV45- and FDG-PET Study of Reversion and Conversion Phenomena. Ashraf-Ganjouei A; Moradi K; Faghani S; Abdolalizadeh A; Khomeijani-Farahani M; Fatehi F; Alzheimer's Disease Neuroimaging Initiative Curr Alzheimer Res; 2021; 18(9):721-731. PubMed ID: 34819007 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic Stability of Mild Cognitive Impairment, and Predictors of Reversion to Normal Cognitive Functioning. Overton M; Pihlsgård M; Elmståhl S Dement Geriatr Cogn Disord; 2019; 48(5-6):317-329. PubMed ID: 32224608 [TBL] [Abstract][Full Text] [Related]
19. Reversible predictors of reversion from mild cognitive impairment to normal cognition: a 4-year longitudinal study. Shimada H; Doi T; Lee S; Makizako H Alzheimers Res Ther; 2019 Mar; 11(1):24. PubMed ID: 30867057 [TBL] [Abstract][Full Text] [Related]
20. Neuropsychiatric Symptoms and the Diagnostic Stability of Mild Cognitive Impairment. Sugarman MA; Alosco ML; Tripodis Y; Steinberg EG; Stern RA J Alzheimers Dis; 2018; 62(4):1841-1855. PubMed ID: 29614641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]